EW · Categories · Downgrades
EW - Analyst downgrades
Edwards Lifesciences Corporation (EW) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for EW
- Edwards Lifesciences downgraded by OppenheimerOppenheimer downgraded Edwards Lifesciences from Outperform to Perform
- Edwards Lifesciences downgraded by Wolfe Research with a new price targetWolfe Research downgraded Edwards Lifesciences from Peer Perform to Underperform and set a new price target of $60.00
- Edwards Lifesciences downgraded by Jefferies with a new price targetJefferies downgraded Edwards Lifesciences from Buy to Hold and set a new price target of $70.00 from $85.00 previously
- Edwards Lifesciences downgraded by TD Cowen with a new price targetTD Cowen downgraded Edwards Lifesciences from Buy to Hold and set a new price target of $70.00 from $100.00 previously
- Edwards Lifesciences downgraded by BofA Securities with a new price targetBofA Securities downgraded Edwards Lifesciences from Buy to Neutral and set a new price target of $75.00 from $105.00 previously
- Edwards Lifesciences downgraded by Robert W. Baird with a new price targetRobert W. Baird downgraded Edwards Lifesciences from Outperform to Neutral and set a new price target of $70.00 from $102.00 previously
- Edwards Lifesciences downgraded by JP Morgan with a new price targetJP Morgan downgraded Edwards Lifesciences from Overweight to Neutral and set a new price target of $72.00 from $105.00 previously
- Edwards Lifesciences downgraded by Truist with a new price targetTruist downgraded Edwards Lifesciences from Buy to Hold and set a new price target of $82.00 from $110.00 previously
- Edwards Lifesciences downgraded by Evercore ISI with a new price targetEvercore ISI downgraded Edwards Lifesciences from Outperform to In-line and set a new price target of $77.00 from $80.00 previously
- Edwards Lifesciences downgraded by CitigroupCitigroup downgraded Edwards Lifesciences from Buy to Neutral
- Edwards Lifesciences downgraded by Wolfe Research with a new price targetWolfe Research downgraded Edwards Lifesciences from Peer Perform to Underperform and set a new price target of $57.00
- Edwards Lifesciences downgraded by Wells Fargo with a new price targetWells Fargo downgraded Edwards Lifesciences from Overweight to Equal Weight and set a new price target of $78.00 from $97.00 previously
- Edwards Lifesciences downgraded by Raymond JamesRaymond James downgraded Edwards Lifesciences from Outperform to Mkt Perform
- Edwards Lifesciences downgraded by Bernstein with a new price targetBernstein downgraded Edwards Lifesciences from Outperform to Underperform and set a new price target of $66.00 from $95.00 previously
- Edwards Lifesciences downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Edwards Lifesciences from Overweight to Neutral and set a new price target of $80.00 from $95.00 previously
- Edwards Lifesciences downgraded by Stifel with a new price targetStifel downgraded Edwards Lifesciences from Buy to Hold and set a new price target of $75.00 from $95.00 previously
- Edwards Lifesciences downgraded by OppenheimerOppenheimer downgraded Edwards Lifesciences from Outperform to Perform
- Edwards Lifesciences downgraded by Canaccord Genuity with a new price targetCanaccord Genuity downgraded Edwards Lifesciences from Buy to Hold and set a new price target of $106.00 from $115.00 previously